|
Disease |
|
|
|
Detail |
hsa-miR-21 |
|
Causal |
MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. |
2007 |
|
|
|
|
|
|
hsa-miR-21 |
|
Causal |
MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. |
2008 |
|
|
|
|
|
|
hsa-miR-181a |
|
Causal |
hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells.
|
2008 |
|
|
|
|
|
|
hsa-miR-181b |
|
Causal |
hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells.
|
2008 |
|
|
|
|
|
|
hsa-miR-15b |
|
Causal |
MicroRNA-15b regulates cell cycle progression by targeting cyclins in glioma cells. |
2009 |
|
|
|
|
|
|
hsa-miR-296 |
|
Causal |
miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. |
2008 |
|
|
|
|
|
|
hsa-miR-128 |
|
Causal |
MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a. |
2008 |
|
|
|
|
|
|
hsa-miR-146b |
|
Causal |
microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs. |
2009 |
|
|
|
|
|
|
hsa-miR-221 |
|
Causal |
Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo. |
2009 |
|
|
|
|
|
|
hsa-miR-222 |
|
Causal |
Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo. |
2009 |
|
|
|
|
|
|
hsa-miR-26a |
|
Causal |
The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. |
2009 |
|
|
|
|
|
|
hsa-miR-10b |
|
Unspecified |
MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC. |
2009 |
|
|
|
|
|
|
hsa-miR-34a |
|
Causal |
MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes |
2009 |
|
|
|
|
|
|
hsa-miR-130b |
|
Unspecified |
Identification and Functional Characterization of microRNAs Involved in the Malignant Progression of Gliomas |
2009 |
|
|
|
|
|
|
hsa-miR-140 |
|
Unspecified |
Identification and Functional Characterization of microRNAs Involved in the Malignant Progression of Gliomas |
2009 |
|
|
|
|
|
|
hsa-miR-15a |
|
Unspecified |
Identification and Functional Characterization of microRNAs Involved in the Malignant Progression of Gliomas |
2009 |
|
|
|
|
|
|
hsa-miR-16 |
|
Unspecified |
Identification and Functional Characterization of microRNAs Involved in the Malignant Progression of Gliomas |
2009 |
|
|
|
|
|
|
hsa-miR-184 |
|
Causal |
Identification and Functional Characterization of microRNAs Involved in the Malignant Progression of Gliomas |
2009 |
|
|
|
|
|
|
hsa-miR-19a |
|
Unspecified |
Identification and Functional Characterization of microRNAs Involved in the Malignant Progression of Gliomas |
2009 |
|
|
|
|
|
|
hsa-miR-20a |
|
Unspecified |
Identification and Functional Characterization of microRNAs Involved in the Malignant Progression of Gliomas |
2009 |
|
|
|
|
|
|
hsa-miR-21 |
|
Unspecified |
Identification and Functional Characterization of microRNAs Involved in the Malignant Progression of Gliomas |
2009 |
|
|
|
|
|
|
hsa-miR-210 |
|
Unspecified |
Identification and Functional Characterization of microRNAs Involved in the Malignant Progression of Gliomas |
2009 |
|
|
|
|
|
|
hsa-miR-25 |
|
Unspecified |
Identification and Functional Characterization of microRNAs Involved in the Malignant Progression of Gliomas |
2009 |
|
|
|
|
|
|
hsa-miR-28 |
|
Unspecified |
Identification and Functional Characterization of microRNAs Involved in the Malignant Progression of Gliomas |
2009 |
|
|
|
|
|
|
hsa-miR-328 |
|
Unspecified |
Identification and Functional Characterization of microRNAs Involved in the Malignant Progression of Gliomas |
2009 |
|
|
|
|
|
|
hsa-miR-9 |
|
Unspecified |
Identification and Functional Characterization of microRNAs Involved in the Malignant Progression of Gliomas |
2009 |
|
|
|
|
|
|
hsa-miR-17 |
|
Causal |
Identification and Functional Characterization of microRNAs Involved in the Malignant Progression of Gliomas |
2009 |
|
|
|
|
|
|